Performance of Elecsys<sup>®</sup> HCV Duo Immunoassay for Diagnosis and Assessment of Treatment Response in HCV Patients with or without HIV Infection
Background/Objectives: The Elecsys<sup>®</sup> HCV Duo immunoassay (Roche Diagnostics International Ltd., Rotkreuz, Switzerland) detects both antibodies to hepatitis C virus (anti-HCV) and HCV core antigen (HCV-Ag) and has shown excellent diagnostic performance in blood donor samples. We...
Saved in:
| Main Authors: | Prooksa Ananchuensook, Jongkonnee Wongpiyabovorn, Anchalee Avihingsanon, Pisit Tangkijvanich |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-09-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/14/19/2179 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Worsening of Controlled Attenuation Parameter and Metabolic Profile After HCV Cure in People with HIV as a Sign of Steatosis
by: Alessia Siribelli, et al.
Published: (2025-06-01) -
Efficacy and safety of directly acting antiviral drugs in HCV patients with HIV in liver transplantation: A meta-analysis
by: Tian Zeng, et al.
Published: (2023-01-01) -
A comparative national survey on the gradual decline of hepatitis C virus prevalence in Thailand, 2004, 2014, and 2024
by: Sitthichai Kanokudom, et al.
Published: (2025-06-01) -
Sustained virological response in HCV patients receiving antiviral treatment at a teaching centre of northern India
by: Astha, et al.
Published: (2025-03-01) -
Long-Term Hepatic and Extrahepatic Outcomes of Chronic Hepatitis C Patients After Sofosbuvir-Based Treatment (LONGHEAD Study)
by: Chung-Feng Huang, et al.
Published: (2025-04-01)